Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Cutaneous squamous-cell carcinoma

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Synopsis

Recognise invasive cutaneous squamous-cell carcinoma, identify clinical and pathological high-risk features, refer every suspected lesion urgently and coordinate excision, nodal assessment and prevention.

  • Suspect SCC in a persistent enlarging tender indurated keratotic, crusted or ulcerated lesion, particularly on chronically sun-exposed skin.
  • NICE recommends urgent suspected-cancer referral for every lesion clinically suspicious for cutaneous SCC.
  • High-risk features include lip or ear site, diameter over 2 cm, depth over 6 mm or beyond subcutaneous fat, poor differentiation, perineural invasion, recurrence and immune suppression.
  • Palpate the relevant nodal basin and document pain, numbness or weakness because clinical perineural and nodal disease alter urgency and staging.
  • Excision with histological margin assessment is standard; Mohs or wider specialist surgery is considered for high-risk, recurrent or tissue-critical tumours.
  • Do not curette, freeze or treat with field cream when invasive SCC is plausible; these approaches can delay depth and margin diagnosis.
  • A cutaneous horn is a reaction pattern, not a diagnosis; assess and sample the indurated base where SCC may be present.
  • Immune-suppressed patients need a lower biopsy threshold, rapid pathways and multidisciplinary review of prevention and immunosuppression.

Key red flags

Rapid growth, severe pain, numbness, fixation, recurrent tumour, lip or ear site, diameter over 2 cm, immune suppression, palpable nodes or chronic-scar ulceration requires urgent suspected-cancer referral and high-risk staging.

Lip or ear tumour

Persistent keratotic ulceration on vermilion lip or pinna carries higher metastatic risk and demands urgent referral.

Perineural symptoms

Pain, tingling, numbness, facial weakness or other motor loss near a lesion suggests nerve invasion.

Nodal disease

A new firm regional node, parotid mass or in-transit nodule may represent metastasis and requires urgent imaging and sampling.

Investigation priorities

01
Deep representative biopsyFirst step

Confirm SCC and measure invasive and pathological risk features.

Management branches

Suspected SCCRefer every invasive suspicion urgently

A persistent indurated keratotic, ulcerated or rapidly growing lesion could represent invasive SCC.

  1. Measure and document morphology, growth, site, immune status, neurological symptoms and regional nodes.
  2. Make an urgent suspected-cancer referral, leaving the lesion available for appropriately deep biopsy and definitive planning.
  3. Safety-net accelerated growth, bleeding, pain, numbness or nodes and track attendance and pathology outcome.
Open full textbook →Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG12 suspected cutaneous SCC referralUrgent referral requirement.
  • British Association of Dermatologists squamous-cell carcinomaRecognition, high-risk features, treatment and follow-up.
  • BAD cutaneous SCC guideline 2020Risk stratification, surgery, staging and surveillance.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom